UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

Nature biotechnology, 2016-02, Vol.34 (2), p.155-163

2016

Volltextzugriff (PDF)

MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome

Nucleic acids research, 2010-01, Vol.38 (2), p.391-399

2010

Volltextzugriff (PDF)

Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1211-1218

2013

Volltextzugriff (PDF)

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target

Clinical cancer research, 2019-01, Vol.25 (1), p.210-221

2019

Volltextzugriff (PDF)

Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1

The Journal of biological chemistry, 2005-12, Vol.280 (49), p.40749-40756

2005

Volltextzugriff (PDF)

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

The Prostate, 2011-03, Vol.71 (4), p.333-343

2011

Volltextzugriff (PDF)

Processing and cryopreservation of human ureter tissues for single-cell and spatial transcriptomics assays

STAR protocols, 2022-12, Vol.3 (4), p.101854-101854, Article 101854

2022

Volltextzugriff (PDF)

A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (8), p.2570-2575

2008

Volltextzugriff (PDF)

GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells

The American journal of pathology, 2001-11, Vol.159 (5), p.1815-1826

2001

Volltextzugriff (PDF)

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (6), p.814-829

2023

Volltextzugriff (PDF)

Unique DNA methylome profiles in CpG island methylator phenotype colon cancers

Genome research, 2012-02, Vol.22 (2), p.283-291

2012

Volltextzugriff (PDF)

Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

European urology oncology, 2023-12, Vol.6 (6), p.590-596

2023

Volltextzugriff (PDF)

Robotic radical cystectomy with intracorporeal urinary diversion: beyond the initial experience

Translational andrology and urology, 2020-04, Vol.9 (2), p.942-948

2020

Volltextzugriff (PDF)

Neuroinflammatory gene expression analysis reveals potential novel mediators and treatment targets in interstitial cystitis with Hunner lesions

Translational andrology and urology, 2021-11, Vol.10 (11), p.4100-4109

2021

Volltextzugriff (PDF)

Abnormal DNA methylation, epigenetics, and prostate cancer

Frontiers in bioscience, 2007-05, Vol.12 (8-12), p.4254

2007

Volltextzugriff (PDF)

Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma

European urology focus, 2018-01, Vol.4 (1), p.100-105

2018

Volltextzugriff (PDF)

Laparoscopic-assisted vesicocalicostomy for severe pelvi-ureteral stricture disease

Journal of the Society of Laparoendoscopic Surgeons, 2013, Vol.17 (3), p.468-470

2013

Volltextzugriff (PDF)

Plasmacytoid variant urothelial carcinoma: Clinicopathologic outcomes and experience with neoadjuvant chemotherapy

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.483-483

2019

Volltextzugriff (PDF)

Laparoscopic-assisted vesicocalicostomy for severe pelvi-ureteral stricture disease

Journal of the Society of Laparoendoscopic Surgeons, 2012-01, Vol.16 (1), p.163-165

2012

Volltextzugriff (PDF)

Impact of preoperative neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) on overall survival or recurrence free survival in muscle-invasive bladder cancer at cystectomy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17050-e17050

2020

Volltextzugriff (PDF)

Abstract 4733: Effect of KDM6A mutation in bladder cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4733-4733

2023

Volltextzugriff (PDF)

A novel orthotopic murine model of neuroendocrine bladder cancer: Insights into the phenotypic plasticity of small cell bladder cancer (SCBC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.571-571

2020

Volltextzugriff (PDF)

Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder cancer (BC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4523-4523

2019

Volltextzugriff (PDF)

Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (met) bladder cancer (BC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4528-4528

2019

Volltextzugriff (PDF)

Blood myeloid derived suppressor cells (MDSC) in metastatic urothelial carcinoma (mUC) are correlated with neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.436-436

2019

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Englisch
(187)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome

Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target

Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

Processing and cryopreservation of human ureter tissues for single-cell and spatial transcriptomics assays

A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells

GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Unique DNA methylome profiles in CpG island methylator phenotype colon cancers

Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

Robotic radical cystectomy with intracorporeal urinary diversion: beyond the initial experience

Neuroinflammatory gene expression analysis reveals potential novel mediators and treatment targets in interstitial cystitis with Hunner lesions

Abnormal DNA methylation, epigenetics, and prostate cancer

Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma

Laparoscopic-assisted vesicocalicostomy for severe pelvi-ureteral stricture disease

Plasmacytoid variant urothelial carcinoma: Clinicopathologic outcomes and experience with neoadjuvant chemotherapy

Laparoscopic-assisted vesicocalicostomy for severe pelvi-ureteral stricture disease

Impact of preoperative neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) on overall survival or recurrence free survival in muscle-invasive bladder cancer at cystectomy

Abstract 4733: Effect of KDM6A mutation in bladder cancer

A novel orthotopic murine model of neuroendocrine bladder cancer: Insights into the phenotypic plasticity of small cell bladder cancer (SCBC)

Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder cancer (BC)

Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (met) bladder cancer (BC)

Blood myeloid derived suppressor cells (MDSC) in metastatic urothelial carcinoma (mUC) are correlated with neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS)

Aktive Filter

Suchergebnisse filtern